rdf:type |
|
lifeskim:mentions |
umls-concept:C0006610,
umls-concept:C0007082,
umls-concept:C0007634,
umls-concept:C0030705,
umls-concept:C0041361,
umls-concept:C0075091,
umls-concept:C0220901,
umls-concept:C0237881,
umls-concept:C0680730,
umls-concept:C0684249,
umls-concept:C0750502,
umls-concept:C0936012,
umls-concept:C1148554,
umls-concept:C1383501
|
pubmed:issue |
6
|
pubmed:dateCreated |
1996-7-9
|
pubmed:abstractText |
The use of new prognostic factors as guidelines for the indication of treatment ancillary to surgery has been advocated for patients with nonsmall cell lung carcinoma (NSCLC). This article is an analysis of the prognostic information derived from determination of tumor-tissue cytosolic concentration of CA 125 tumor-associated antigen (CA 125), carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in patients with NSCLC.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1066-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8635125-Adult,
pubmed-meshheading:8635125-Aged,
pubmed-meshheading:8635125-Aged, 80 and over,
pubmed-meshheading:8635125-Antigens, Neoplasm,
pubmed-meshheading:8635125-CA-125 Antigen,
pubmed-meshheading:8635125-Carcinoembryonic Antigen,
pubmed-meshheading:8635125-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:8635125-Cytosol,
pubmed-meshheading:8635125-Female,
pubmed-meshheading:8635125-Humans,
pubmed-meshheading:8635125-Lung Neoplasms,
pubmed-meshheading:8635125-Male,
pubmed-meshheading:8635125-Middle Aged,
pubmed-meshheading:8635125-Prognosis,
pubmed-meshheading:8635125-Serpins,
pubmed-meshheading:8635125-Tumor Markers, Biological
|
pubmed:year |
1996
|
pubmed:articleTitle |
Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
|
pubmed:affiliation |
Department of Surgery, Hospital Universitario, San Carlos, Madrid, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|